Intravenous Paracetamol Versus Intramuscular Tramadol in Shortening the Duration of Labour.
1 other identifier
interventional
189
1 country
1
Brief Summary
It is a well established fact that the pain of labour can be excrutiating and ways to shorten the duration of labour has been sought after. this study compares the role of intramuscular tramadol and intravenous paracetamol in shortening the duration of labour
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2023
CompletedFirst Submitted
Initial submission to the registry
January 30, 2026
CompletedFirst Posted
Study publicly available on registry
February 6, 2026
CompletedFebruary 6, 2026
January 1, 2026
4 months
January 30, 2026
January 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean duration of first, second and third stage of labour
the mean of the different stages of labour as well as the total duration of labour
12 hours
Study Arms (2)
intramuscular tramadol
ACTIVE COMPARATOR100mg of tramadol was given intramuscularly in active phase of labour
paracetamol
EXPERIMENTAL1000mg of paracetamol given intravenously in active phase of labour
Interventions
100mg of tramadol given in active phase of labour
1000 mg of paracetamol was administered intravenously to participants in active phase of labour
Eligibility Criteria
You may qualify if:
- Spontaneous active phase labour
- No contraindication to vaginal delivery
You may not qualify if:
- Clinical evidence of cephalopelvic disproportion
- Malpresentation,
- Multiple pregnancy,
- Previously scarred uterus,
- Preterm labour,
- Induced labour
- Antepartum hemorrhage.
- History of known allergy to tramadol and paracetamol or opioids or
- History of narcotics dependency.
- History of renal disease,
- Fetal distress
- Intrauterine fetal death.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assumpta Nnenna Nweke
Abakaliki, Ebonyi State, 480, Nigeria
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Assumpta N Nweke
ST Patrick Mission Hospital, Mile $ Abakaliki, Ebonyi State
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 30, 2026
First Posted
February 6, 2026
Study Start
November 1, 2022
Primary Completion
February 25, 2023
Study Completion
February 25, 2023
Last Updated
February 6, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share